QuidelOrtho Income Statement
QDEL / Health Care|5 years of annual SEC 10-K data (FY2020-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$2.7B
FY2025
Gross Profit
N/A
FY2025
Operating Income
-$919M
FY2025
Net Income
-$1.1B
FY2025
QuidelOrtho reported $2.7B in revenue and $1.1B in net loss for FY2025. Revenue has grown at a 10.4% compound annual rate over the past 5 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.7B | $2.8B | $3.0B | $3.3B | $1.7B |
| SG&A Expense | $746.3M | $766.8M | $763.2M | $621.0M | $180.7M |
| R&D Expense | $186.2M | $218.7M | $245.0M | $187.9M | $84.3M |
| Operating Income | -$919.2M | -$2.0B | $139.1M | $843.7M | $1.1B |
| Interest Expense | - | - | - | - | -$8.5M |
| Income Tax | $24.1M | -$79.5M | -$19.0M | $187.2M | $230.0M |
| Net Income | -$1.1B | -$2.1B | -$10.1M | $548.7M | $810.3M |
| EPS (Basic) | -$0.15 | $9.66 | $16.74 | $19.24 | $19.24 |
| EPS (Diluted) | -$0.15 | $9.56 | $16.43 | $18.60 | $18.60 |
| Shares Outstanding | 67.3M | 66.7M | 66.4M | 41.7M | 43.6M |
| Operating Margin | -33.7% | -70.5% | 4.6% | 25.8% | 63.8% |
| Profit Margin | -41.4% | -73.7% | -0.3% | 16.8% | 48.8% |